Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Boehringer Ingelheim Gains China Approval for HERNEXEOS in Unresectable NSCLC
China's NMPA clears Boehringer Ingelheim's HERNEXEOS as monotherapy for unresectable, locally advanced or metastatic NSCLC in adults.
Pharma Now Editorial Team
Novo Nordisk POSEIDON Study Finds CV Inflammation in 2 in 5 High-Risk Patients Globally
Novo Nordisk's POSEIDON study finds CV inflammation in 40% of high-risk CVD patients globally, signalling a treatment gap and potential first-in-class drug pathway.
Pharma Now Editorial Team
Novartis Presents Phase III Kidney Data at ERA 2026 for Vanrafia and Fabhalta
Novartis presents 15 kidney disease abstracts at ERA 2026, including late-breaking Phase III data for Vanrafia and Fabhalta with European regulatory implications.
Pharma Now Editorial Team
Amgen Appoints Madhur Sarin as Director of AI and Data Science Centre of Excellence
Amgen formalises AI leadership with a dedicated COE director, signalling structural integration of data science into manufacturing, quality, and regulatory operations.
Pharma Now Editorial Team
